These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12594127)

  • 1. Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
    Licata G; Pinto A; Tuttolomondo A; Banco A; Ciccia F; Ferrante A; Triolo G
    Ann Rheum Dis; 2003 Mar; 62(3):280-1. PubMed ID: 12594127
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
    Andonopoulos AP; Meimaris N; Daoussis D; Bounas A; Yiannopoulos G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S57-8. PubMed ID: 14727465
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy.
    Goossens PH; Verburg RJ; Breedveld FC
    Ann Rheum Dis; 2001 Jun; 60(6):637. PubMed ID: 11350856
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease.
    Triolo G; Vadalà M; Accardo-Palumbo A; Ferrante A; Ciccia F; Giardina E; Citarrella P; Lodato G; Licata G
    Ann Rheum Dis; 2002 Jun; 61(6):560-1. PubMed ID: 12006336
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
    Sfikakis PP; Theodossiadis PG; Katsiari CG; Kaklamanis P; Markomichelakis NN
    Lancet; 2001 Jul; 358(9278):295-6. PubMed ID: 11498218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
    Fujikawa K; Aratake K; Kawakami A; Aramaki T; Iwanaga N; Izumi Y; Arima K; Kamachi M; Tamai M; Huang M; Nakamura H; Nishiura Y; Origuchi T; Ida H; Eguchi K
    Ann Rheum Dis; 2007 Jan; 66(1):136-7. PubMed ID: 17178762
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of long-standing neuro-Behçet's disease with infliximab.
    Sarwar H; McGrath H; Espinoza LR
    J Rheumatol; 2005 Jan; 32(1):181-3. PubMed ID: 15630746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 11. Remission of Behçet's syndrome with TNFalpha blocking treatment.
    Rozenbaum M; Rosner I; Portnoy E
    Ann Rheum Dis; 2002 Mar; 61(3):283-4. PubMed ID: 11830448
    [No Abstract]   [Full Text] [Related]  

  • 12. [Spondylarthropathy with Behçet's disease: response to infliximab].
    Toussirot E; Schwartz C; Hafsaoui C; Bossert M; Bertolini E; Wendling D
    Presse Med; 2009; 38(7-8):1183-5. PubMed ID: 19395229
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
    Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
    Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory primary central nervous system vasculitis of childhood: successful treatment with infliximab.
    Batthish M; Banwell B; Laughlin S; Halliday W; Peschken C; Paras E; Benseler S
    J Rheumatol; 2012 Nov; 39(11):2227-9. PubMed ID: 23118297
    [No Abstract]   [Full Text] [Related]  

  • 16. Behçet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
    Kram MT; May LD; Goodman S; Molinas S
    Dis Colon Rectum; 2003 Jan; 46(1):118-21. PubMed ID: 12544532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's disease.
    Nakamura S; Ohno S
    Int Ophthalmol Clin; 2005; 45(2):179-89. PubMed ID: 15791165
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients.
    Lanthier N; Parc C; Scavennec R; Dhôte R; Brézin AP; Guillevin L
    Presse Med; 2005 Jul; 34(13):916-8. PubMed ID: 16142147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behçet's disease: a new target for anti-tumour necrosis factor treatment.
    Sfikakis PP
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii51-3. PubMed ID: 12379622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G; Velken M; Johnsen V
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.